Manufacturers Life Insurance Company, The Cytom X Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $45,941 - $86,778	-30,027 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$2.67 - $4.68 $80,172 - $140,526	30,027 New	30,027 $80,000
Q1 2022 May 20, 2022	SELL	$2.67 - $4.68 $16,882 - $29,591	-6,323 Reduced 17.39%	30,027 $80,000
Q4 2021 Feb 16, 2022	SELL	$3.87 - $7.39 $6,509 - $12,429	-1,682 Reduced 4.42%	36,350 $157,000
Q3 2021 Nov 12, 2021	SELL	$4.32 - $6.43 $5,395 - $8,031	-1,249 Reduced 3.18%	38,032 $194,000
Q2 2021 Aug 12, 2021	BUY	$6.33 - $9.91 $11,773 - $18,432	1,860 Added 4.97%	39,281 $249,000
Q1 2021 May 03, 2021	BUY	$6.6 - $9.0 $48,483 - $66,114	7,346 Added 24.43%	37,421 $289,000
Q4 2020 Feb 12, 2021	BUY	$6.47 - $7.9 $15,845 - $19,347	2,449 Added 8.86%	30,075 $197,000
Q2 2020 Aug 10, 2020	SELL	$7.4 - $14.64 $17,397 - $34,418	-2,351 Reduced 7.84%	27,626 $227,000
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $5,129 - $12,220	1,421 Added 4.98%	29,977 $230,000
Q4 2019 Feb 14, 2020	SELL	$5.17 - $8.91 $2,884 - $4,971	-558 Reduced 1.92%	28,556 $237,000
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $7,882 - $9,618	-843 Reduced 2.81%	29,114 $327,000
Q1 2019 May 13, 2019	BUY	$9.5 - $19.16 $23,180 - $46,750	2,440 Added 8.87%	29,957 $322,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $23,083 - $33,851	-1,819 Reduced 6.2%	27,517 $416,000
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $4,528 - $6,628	251 Added 0.86%	29,336 $543,000
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $153,166 - $212,627	7,164 Added 32.68%	29,085 $666,000
Q1 2018 May 15, 2018	SELL	$21.76 - $34.22 $15,340 - $24,125	-705 Reduced 3.12%	21,921 $624,000
Q4 2017 Feb 08, 2018	SELL	$19.0 - $23.09 $7,239 - $8,797	-381 Reduced 1.66%	22,626 $477,000
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $311,284 - $418,037	23,007	23,007 $418,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

49.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.56 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.39 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.34 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.04 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.6 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account